Pfizer plans to drastically ramp up its vaccine production capacity and is prepared to drop German firm that it partnered with on breakthrough Covid jabs
New York-based Pfizer said it had learned everything it needs to about mRNA vaccines in the last year to go solo, adding that it no longer 'needs to work with BioNTech'.
